Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma

Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma : A Narrative Review and Critical Appraisal of Current Regulations / Hayden Allen, Susan H. Backhouse, James H. Hull, Oliver J. Price . - (Sports Medicine (2019) 18 March; p. 1-10).
- PMID: 30887312.
- DOI: 10.1007/s40279-019-01075-z
___________________________________________________

Abstract

Asthma is prevalent in athletes and when untreated can impact both respiratory health and sports performance. Pharmacological inhaler therapy currently forms the mainstay of treatment; however, for elite athletes competing under the constraints of the World Anti-Doping Code (Code), a number of established therapies are prohibited both in and/or out of competition and/or have a maximum permitted dose. The recent release of medical information detailing inhaler therapy in high-profile athletes has brought the legitimacy and utilisation of asthma medication in this setting into sharp focus. This narrative review critically appraises recent changes to anti-doping policy and the Code in the context of asthma management, evaluates the impact of asthma medication use on sports performance and employs a theory of behaviour to examine perceived determinants and barriers to athletes adhering to the anti-doping rules of sport when applied to asthma.

show »
Type:
pdf

Parameters:

Science
Review
Date:
18 March 2019
People
Allen, Hayden
Backhouse, Susan H.
Hull, James H.
Price, Oliver J.
Country
United Kingdom
Language
English
Legal Terms
Anti-Doping policy
WADA Code, Guidelines, Protocols, Rules & Regulations
Other organisations
Imperial College London
Leeds Beckett University (LBU)
Royal Brompton Hospital
Doping classes
S3. Beta-2 Agonists
S9. Glucocorticosteroids
Substances
Betamethasone
Budesonide
Dexamethasone
Fenoterol
Fluticasone
Formoterol
Higenamine
Hydrocortisone
Indacaterol
Methylprednisolone
Olodaterol
Prednisolone
Prednisone
Salbutamol
Salmeterol
Terbutaline
Triamcinolone
Tulobuterol
Vilanterol
Medical terms
Asthma
Legitimate Medical Treatment
Therapeutic Use Exemption (TUE)
Document category
Scientific article
Document type
pdf
Category
  • Legal
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin